Quarterly report pursuant to Section 13 or 15(d)

Cover

v3.22.1
Cover - shares
 9 Months Ended
Sep. 30, 2021
Nov. 11, 2021
Cover [Abstract]    
Entity Registrant Name Zivo Bioscience, Inc.  
Entity Central Index Key 0001101026  
Document Type 10-Q/A  
Amendment Flag true  
Current Fiscal Year End Date --12-31  
Entity Small Business true  
Entity Shell Company false  
Entity Emerging Growth Company false  
Entity Current Reporting Status Yes  
Document Period End Date Sep. 30, 2021  
Entity Filer Category Non-accelerated Filer  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2021  
Entity Common Stock Shares Outstanding   9,419,660
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 000-30415  
Entity Incorporation State Country Code NV  
Entity Tax Identification Number 87-0699977  
Entity Address Address Line 1 21 East Long Lake Road, Suite 100, Bloomfield Hills, MI 48304  
Entity Address Address Line 2 Suite 100  
Entity Address City Or Town Bloomfield Hills  
Entity Address State Or Province MI  
Entity Address Postal Zip Code 48304  
City Area Code 248  
Local Phone Number 452 9866  
Security 12b Title Common Stock, par value $0.001 per share  
Trading Symbol ZIVO  
Security Exchange Name NASDAQ  
Entity Interactive Data Current Yes  
Amendment Description Zivo Bioscience, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-Q/A (this “Amendment No. 1”) to amend its Quarterly Report on Form 10-Q for the quarterly period September 30, 2021, filed with the Securities and Exchange Commission (the “SEC”) on November 15, 2021 (the “Original Filing”). The purpose of this Amendment No. 1 is to restate our previously issued unaudited interim condensed consolidated financial statements for the three and nine months ended September 30, 2021, contained in the Original Filing (the “Restatement”).